Tannic acid is more effective than clofibrate for the elevation of hepatic β-oxidation and the inhibition of 3-hydroxy-3-methyl-glutaryl-CoA reductase and aortic lesion formation in apo E-deficient mice

British Journal of Nutrition

Volumn 106, Issue 12, 2011, Pages 1855-1863

  Do, Gyeong Min ^a   Kwon, Eun Young ^a   Ha, Tae Youl ^b   Bok Park, Yong ^a   Kim, Hye Jin ^c   Jeon, Seon Min ^a   Lee, Mi Kyung ^d   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c CJ Corporation   (South Korea)

^d Sunchon National University   (South Korea)

Author keywords

Oxidation; 3 Hydroxy 3 methyl glutaryl CoA reductase; Clofibrate; Liver: mRNA expression: Tannic acid

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CARNITINE PALMITOYLTRANSFERASE; CLOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; APO E GENE; ARTICLE; BIOACCUMULATION; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; GENE; GENE DELETION; GENE EXPRESSION; LIPID BLOOD LEVEL; LIPOLYSIS; LIVER LEVEL; MALE; MOUSE; NONHUMAN; WILD TYPE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BASE SEQUENCE; CHOLESTEROL; CLOFIBRATE; DNA PRIMERS; GENE EXPRESSION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; LIPIDS; LIVER; MALE; MICE; MICE, KNOCKOUT; OXIDATION-REDUCTION; PPAR ALPHA; RNA, MESSENGER; TANNINS;

EID: 82555183097     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451100256X     Document Type: Article

References (51)

1. Block G, Patterson B & Subar A (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18, 1-29.
2. Willett WC (1994) Diet and health: what should we eat? Science 264, 532-537. (Pubitemid 24185857)
3. Han X, Shen T & Lou H (2007) Dietary polyphenols and their biological significance. Int J Mol Sci 8, 950-988. (Pubitemid 47523244)
4. Shahidi F & Naczk M (1995) Food Phenolics: Sources; Chemistry; Effects; Applications. Lancaster, Pennsylvania: Technomic Publishing, Inc.
5. Higdon JA & Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. CRC Crit Rev Food Sci Nutr 43, 89-143. (Pubitemid 38552312)
6. Santos-Buelga C & Scalbert A (2000) Proanthocyanidins and tannin-like compounds-nature, occurrence, dietary intake and effects on nutrition and health. J Sci Food Agric 80, 1094-1117. (Pubitemid 30319402)
7. Ragan MA & Glombitza K (1986) Phlorotannins: brown algal polyphenols. Prog Phycol Res 4, 177-241.
8. Clifford MN & Scalbert A (2000) Ellagitannins-nature, occurrence and dietary burden. J Sci Food Agric 80, 1118-1125.
9. Haslam E (1989) Plant Polyphenols-Vegetable Tannins Revisited. Cambridge: Cambridge University Press.
10. Okuda T, Yoshida T & Hatano T (1995) Hydrolyzable tannins and related polyphenols. Fortschr Chem Org Naturst 66, 1-117.
11. Hagerman AE, Riedl KM, Jones JA, et al. (1998) High molecular weight plant polyphenolics (tannins) as biological antioxidants. J Agric Food Chem 46, 1887-1892. (Pubitemid 128492929)
12. Gyamifi MA & Aniya Y (2002) Antioxidant properties of Thonningianin A, isolated from the African meficifnal herb, Thonningia sanguinia. Biochem Pharmacol 63, 1725-1737. (Pubitemid 34460702)
13. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12, 564-582. (Pubitemid 29484747)
14. Yugarani T, Tan BKH & Das NP (1993) The effects of tannic acid on serum and liver lipids of RAIF and RICO rats fed on high fat diet. Comp Biochemi Physiol 104, 339-343. (Pubitemid 23045635)
15. Lardenoye JH, Delsing DJ, de Vries MR, et al. (2000) Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE3Leiden transgenic mice. Circ Res 87, 248-253. (Pubitemid 30627538)
16. Nagasawa T, Inada Y, Nakano S, et al. (2006) Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine-and choline-deficient diet. Eur J Pharmacol 24, 182-191.
17. Tosh D, Alberti KG & Agius L (1989) Clofibrate induces car-nitine acyltransferases in periportal and perivenous zones of rat liver and does not disturb the acinar zonation of gluco-neogenesis. Biochim Biophys Acta 992, 245-250. (Pubitemid 19220885)
18. Bligh EG & Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
19. Moghadasian MH, Mcmanus BM, Pritchard PH, et al. (1997) Tall oil-derived phytosterols reduce atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 17, 119-126. (Pubitemid 27057333)
20. Hulcher FH & Oleson WH (1973) Simplified spectrophoto-metric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 14, 625-631.
21. Shapiro DJ, Nordstrom JL, Mitschelen JJ, et al. (1974) Micro assay for 3-hydroxy-3-methylglutaryl CoA reductase in rat liver and in L-cell fibroblasts. Biochim Biophys Acta 370, 369-377.
22. Gillies PJ, Rathgeb KA, Perri MA, et al. (1986) Regulation of acyl-CoA:cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: role of a cholesterol substrate pool. Exp Mol Pathol 44, 320-339.
23. Carl MN, Lakshmanan MR & Porter JW (4000) Fatty acid synthase from rat liver. Methods Enzymol 35, 37-44.
24. Markwell MAK, McGroarty EJ, Bieber LL, et al. (1973) The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. J Biol Chem 248, 3426-3432.
25. Lazarow PB (1981) Assay of peroxisomal b-oxidation of fatty acids. Methods Enzymol 72, 315-319.
26. -DDCt method. Methods 25, 402-408. (Pubitemid 34164012)
27. Nathan JD, Zdankiewicz PD, Wang J, et al. (2001) Impaired hepatocyte glucose transport protein (GLUT2) internaliz-ation in chronic pancreatitis. Pancreas 22, 172-178. (Pubitemid 32179172)
28. Okuda T & Yoshida T (1992) Polyphenols from Asian plants-structural diversity, and antitumor and antiviral activities. Phenolic compounds in food and their effects on health II. ACS Symposium Series 507, 160-183.
29. Bravo L, Abia R, Eastwood MA, Saura-Calixto F, et al. (1994) Degradation of polyphenols in the rat intestinal tract. Effect on colonic fermentation and fecal output. Br J Nutr 71, 933-946. (Pubitemid 24186271)
30. Lapinskas P, Corton C, Puga A, et al. (1999) Molecular mechanisms of hepatocarcinogenic peroxisome proliferators. In Molecular Biology of the Toxic Response. Philadelphia: Taylor and Francis.
31. Lindquist PJ, Svensson LT & Alexson SE (1998) Molecular cloning of the peroxisome proliferators-induced 46 kDa cytosolic acyl CoA thioesterase from mouse and rat liver-recombinant expression in Escherichia coli, tissue expression and nutritional regulation. Eur J Biochem 251, 631-640. (Pubitemid 28108956)
32. Tebib K, Besancon P & Rouanet J-M (1994) Polymeric grape seed tannins prevent plasma cholesterol changes in high-cholesterol-fed rats. Food Chem 49, 4403-4406.
33. Linton MF & Fazio S (2000) Re-emerence of fibrates in the management of dyslipidemia and cardiovascular risk. Curr Atheroscler Rep 2, 29-35.
34. Pászty C, Maeda N, Verstuyft J, et al. (1994) Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 94, 899-903.
35. Tkác I, Kimball BP, Lewis G, et al. (1997) The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. Arterioscler Thromb Vasc Biol 17, 3633-3638. (Pubitemid 28028578)
36. Tardif JC, Heinonen T & Noble S (2009) High-density lipoprotein/apolipoprotein A-I infusion therapy. Curr Ather-oscler Rep 11, 58-63.
37. Dansky HM, Charlton SA, Barlow CB, et al. (1999) The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipo-protein particles. Clin Invest 104, 31-39.
38. Bocan TM, Mueller SB & Brown EQ (1998) HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion in the cholesterol-fed rabbit. Atherosclerosis 139, 21-30. (Pubitemid 28341863)
39. Suckling KE & Stange EF (1985) Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res 26, 647-671. (Pubitemid 15248938)
40. Do GM, Kwon EY, Kim HJ, et al. (2008) Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun 374, 55-59.
41. Oguchi S, Dimayuga P, Zhu J, et al. (2000) Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 20, 1729-1736. (Pubitemid 30470587)
42. Imai K & Nakachi K (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310, 693-696.
43. Gobin S, Bonnefont JP, Prip-Buus C, et al. (2002) Organization of the human liver carnitine palmitoyltransferase 1 gene (CPT1A) and identification of novel mutations in hypo-ketotic hypoglycaemia. Hum Genet 111, 179-189. (Pubitemid 36075037)
44. Ohhira M, Motomura W, Fukuda M, et al. (2007) Lipopoly-saccharide induces adipose differentiation-related protein expression and lipid accumulation in the liver through inhibition of fatty acid oxidation in mice. J Gastroenterol 42, 969-978.
45. Lock EA, Mitchell AM & Elcombe CR (1989) Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29, 145-163. (Pubitemid 19107350)
46. Gloerich J, van Vlies N, Jansen GA, et al. (2005) A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPARalpha-dependent and-independent pathways. J Lipid Res 46, 716-726. (Pubitemid 43073281)
47. Ringseis R & Eder K (2009) Influence of pharmacological PPARalpha activators on carnitine homeostasis in proliferating and non-proliferating species. Pharmacol Res 60, 179-184.
48. Dulloo AG, Duret C, Rohrer D, et al. (1999) Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70, 1040-1045.
49. Stefanovic-Racic M, Perdomo G, Mantell BS, et al. (2008) A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am J Physiol Endocrinol Metab 294, E969-E977.
50. Akkaoui M, Cohen I, Esnous C, et al. (2009) Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids. Biochem J 27 420, 429-438.
51. Glick Z & Joslyn MA (1970) Food intake depression and other metabolic effects of tannic acid in the rat. J Nutr 100, 509-515.